Position in LLY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$9,873,708
+$2,478,758 QoQ
Shares Held
8,232
+2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#1,268
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GRIMES & Co WEALTH MANAGEMENT, LLC holds $182,377,413 across 13 Drug Manufacturers - General names. LLY ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
120,363 | $30,568,591 | |
| 2 | AMGN |
Amgen Inc
|
80,582 | $29,180,353 | |
| 3 | ABBV |
AbbVie Inc.
|
103,634 | $26,078,458 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
370,909 | $21,371,776 | |
| 5 | PFE |
Pfizer Inc
|
805,088 | $19,386,518 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
137,963 | $17,430,244 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
8,232 | $9,873,708 | |
| 8 | GSK |
GSK plc
|
182,745 | $9,579,492 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,873,708 | 8,232 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $7,394,950 | 8,040 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $7,181,012 | 6,682 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $4,738,230 | 6,210 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,631,830 | 4,659 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,582,797 | 4,338 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $3,205,344 | 4,152 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,608,433 | 4,073 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $3,392,458 | 3,747 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $2,981,142 | 3,832 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,844,066 | 4,879 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,109,309 | 3,927 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,832,304 | 3,907 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $1,346,206 | 3,920 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,386,167 | 3,789 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $1,221,939 | 3,779 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $1,219,428 | 3,761 | Shares | Other | 2022-07-22 | |
| 2022-03-31 | $1,089,923 | 3,806 | Shares | Other | 2022-05-06 | |
| 2021-12-31 | $1,072,285 | 3,882 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $896,935 | 3,882 | Shares | Other | 2021-11-08 | |
| 2021-06-30 | $878,602 | 3,828 | Shares | Other | 2021-08-04 | |
| 2021-03-31 | $712,530 | 3,814 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $778,014 | 4,608 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $682,075 | 4,608 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $759,167 | 4,624 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $641,440 | 4,624 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||